Scientists at the University of Virginia School of Medicine have uncovered a key reason why some people continue to ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Macrophages are important components of the internal immune cells, which profoundly affects the internal ...

Early diagnosis is crucial in disease prevention and treatment. Many diseases can be identified not just through physical ...

Cellis is bringing the power of cell therapies to solid tumors. By loading macrophages with drugs, the biotech has created a modality that kills cancer cells, reshapes the tumor microenvironment ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

A new study reveals that Epstein-Barr virus (EBV) infection exacerbates ulcerative colitis (UC) by driving macrophage ...